Novel gene edited T cell therapy to treat lymphoma shows promise and little toxicity says newly published results of small clinical trial

After years of effort, this revolutionary gene-modified T cell treatment is bearing fruit in treating lymphoma, a form of cancer.

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →